Dalton Transactions, 44(3), 1406-1411
These data make a fundamental biological point: obesity is a chronic neurobiological disease with a defended set point, not a simple matter of willpower or caloric arithmetic, and pharmacotherapy is maintenance therapy, not a finite course of treatment
MUMBAI: A day after semaglutide lost patent protection in India, top drugmakers including Dr Reddys, Sun Pharma, and Zydus Lifesciences launched generic versions priced 50-90% below the innovator brands, kicking off an aggressive scramble for share in the fast-growing weight-loss and diabetes market
Whether you are a returning member of the community evaluating whether to trust us again, or a researcher encountering this brand for the first time we welcome the same standard from both: judge us by what we demonstrate, not what we claim
doi:10.1007/978-0-387-78518-9_18
Works for my busy lifestyle